上海招聘

Major Responsibilities

Assists Clinical Operations Manager to manage clinical studies or leads clinical studies independently, if required

• Assists Clinical Operations Manager (COM) or leads independently (COM II) to plan, organize, and manage all aspects of assigned clinical trial(s)

• Assists COM or leads independently to manage the efforts of all key functional departments to perform all project-related activities according to project milestones/timelines or leads (ACOM II) these activities, if required.

Performs Quality Oversight Visit (QOV)

• Prepares QOV by being familiar with study protocol, plans, previous monitoring reports, follow-up letters, etc.

• Conducts on-site QOV

• Completes QOV reports

• Follows-up with CROs and relevant parties for actions/ resolutions for issues identified through the QoVs

• Prepares “lessons learnt” document and shares with the clinical operations team after the QoVs

Qualification

• Bachelor’s level degree or above in life sciences, pharmacy, nursing or medical

• 4 years or more years of clinical research experience in the Pharmaceutical, CRO or relevant filed

• Excellent communication and interpersonal skills

• Excellent organizational skills and ability to prioritize and multi-task

• Fluent in English (writing and speaking)

百济神州是一家植根中国的全球性商业化生物医药公司，致力于成为分子靶向药物和免疫肿瘤药物研发，及商业创新领域的全球领导者。
2017年，百济神州与新基公司达成战略合作伙伴关系，向新基转让了tislelizumab在美国、欧洲、日本和亚洲以外的其他地区的实体瘤开发和商业化的独家权益，保留了在亚洲（除日本外）开发和商业化tislelizumab用于治疗实体瘤的权益，以及用于治疗恶性血液肿瘤和进行内部组合疗法的全球范围权益。

此外，百济神州获得了新基公司在华获批药物——注射用白蛋白紫杉醇（ABRAXANE？）, 瑞复美（REVLIMID？）和 维达莎（VIDAZA？）的独家授权，并接管其在华商业运营团队。

2018年1月，百济与Mirati公司sitravatinib在亚太地区的独家授权协议，进一步拓宽了公司的产品组合。

截至目前，百济神州在全球各地拥有超过1100名员工，其中包括在中国、美国、澳大利亚和瑞士的超过650名科学家及临床医学专家。

公司在中国的北京、上海、美国的马萨诸塞州Cambridge，新泽西州Fort Lee和加利福尼亚州旧金山Emeryville和San Mateo，瑞士的巴塞尔均设有办事机构。除此之外，百济神州在中国大陆还拥有位于北京的研发中心，苏州、广州两大生产基地，以及在上海的商业运营中心。